Epidemiology

You have full text access to this OnlineOpen article

Characteristics of menstruation and pregnancy and the risk of lung cancer in women

  1. Anita Koushik1,2,*,
  2. Marie-Élise Parent2,3,
  3. Jack Siemiatycki1,2

Article first published online: 11 MAY 2009

DOI: 10.1002/ijc.24560

Issue

International Journal of Cancer

International Journal of Cancer

Volume 125, Issue 10, pages 2428–2433, 15 November 2009

Additional Information

How to Cite

Koushik, A., Parent, M.-É. and Siemiatycki, J. (2009), Characteristics of menstruation and pregnancy and the risk of lung cancer in women. Int. J. Cancer, 125: 2428–2433. doi: 10.1002/ijc.24560

Author Information

  1. 1

    Département de médecine sociale et préventive, Université de Montréal, Montréal, QC, Canada

  2. 2

    Axe Santé des populations, Centre de recherche du CHUM, Montréal, QC, Canada

  3. 3

    INRS—Institut Armand-Frappier, Université du Québec, Laval, QC, Canada

*Axe Santé des populations, Centre de recherche du CHUM, 3875 rue Saint-Urbain, 3e étage, Montréal, QC H2V 1W1, Canada

Publication History

  1. Issue published online: 18 SEP 2009
  2. Article first published online: 11 MAY 2009
  3. Manuscript Accepted: 29 APR 2009
  4. Manuscript Received: 29 JAN 2009

Funded by

  • National Health Research and Development Program
  • Canadian Institutes of Health Research

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (88K)

References

  • 1
    IARC. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. Lyon: IARC Press, 2004.
  • 2
    Parkin DM,Sasco AJ. Lung cancer: worldwide variation in occurrence and proportion attributable to tobacco use. Lung Cancer 1993; 9: 1–16.
  • 3
    Abraham J,Gulley JL,Allegra CJ. Bethesda handbook of clinical oncology. Philadelphia: Lippincott Williams & Wilkins, 2005.
  • 4
    Subramanian J,Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 2007; 25: 561–70.
  • 5
    Siegfried JM. Women and lung cancer: does oestrogen play a role? Lancet 2001; 2: 506–13.
  • 6
    Pauk N,Kubik A,Zatloukal P,Krepela E. Lung cancer in women. Lung Cancer 2005; 48: 1–9.
  • 7
    Gao YT,Blot WJ,Zheng W,Ershow AG,Hsu CW,Levin LI,Zhang R,Fraumeni JF. Lung cancer among chinese women. Int J Cancer 1987; 40: 604–9.
  • 8
    Wu AH,Henderson BE,Pike MC,Mimi CY. Smoking and other risk factors for lung cancer in women. J Natl Cancer Inst 1985; 74: 747–51.
  • 9
    Wu AH,Yu MC,Thomas DC,Pike MC,Henderson BE. Personal and family history of lung disease as risk factors for adenocarcinoma. Cancer Res 1988; 48: 7279–84.
  • 10
    Adami HO,Persson I,Hoover R,Schairer C,Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989; 44: 833–9.
  • 11
    Wu-Williams AH,Dai XD,Blot W,Xu ZY,Sun XW,Xiao HP,Stone BJ,Yu SF,Feng YP,Ershow AG,Sun J,Fraumeni JF, et al. Lung cancer among women in north-east China. Br J Cancer 1990; 62: 982–7.
  • 12
    Taioli E,Wynder EL. Re: endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994; 86: 869–70.
  • 13
    Liao ML,Wang JH,Wang HM,Ou AQ,Wang XJ,You WQ. A study of the association between squamous cell carcinoma and adenocarcinoma in the lung, and history of menstruation in Shanghai women, China. Lung Cancer 1996; 14: S215–21.
  • 14
    Blackman JA,Coogan PF,Rosenberg L,Strom BL,Zauber AG,Palmer JR,Langenberg P,Shapiro S. Estrogen replacement therapy and risk of lung cancer. Pharmacoepidemiol Drug Saf 2002; 11: 561–67.
  • 15
    Seow A,Poh WT,Teh M,Eng P,Wang YT,Tan WC,Chia KS,Yu MC,Lee HP. Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: evidence for a protective effect of soy in nonsmokers. Int J Cancer 2002; 97: 365–71.
  • 16
    Olsson H,Bladström A,Ingvar C. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol 2003; 102: 565–70.
  • 17
    Kreuzer M,Gerken M,Heinrich J,Kreienbrock L,Wichmann HE. Hormonal factors and risk of lung cancer among women? Int J Epidemiol 2003; 32: 263–71.
  • 18
    Brenner AV,Wang Z,Kleinerman RA,Lei S,Metayer C,Wang W,Lubin JH. Menstrual and reproductive factors and risk of lung cancer among Chinese women, Eastern Gansu Province, 1994–1998. J Epidemiol 2003; 13: 22–8.
  • 19
    Schabath MW,Wu X,Vassilopoulou-Sellin R,Vaporciyan AA,Spitz MR. Hormone replacement therapy and lung caner risk: a case-control analysis. Clin Cancer Res 2004; 10: 113–23.
  • 20
    Liu Y,Inoue M,Tsugane S. Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer 2005; 117: 662–6.
  • 21
    Elliott AM,Hannaford PC. Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Contraception 2006; 73: 331–5.
  • 22
    Kabat GC,Miller AB,Rohan TE. Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study. Int J Cancer 2007; 120: 2214–20.
  • 23
    Weiss JM,Lacey JV,Jr,Shu XO,Ji BT,Hou L,Yang G,Li H,Rothman N,Blair A,Gao YT,Chow WH,Zheng W. Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 2008; 168: 1319–25.
  • 24
    Schwartz AG,Wenzlaff AS,Prysak GM,Murphy V,Cote ML,Brooks SC,Skafar DF,Lonardo F. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol 2007; 25: 5785–92.
  • 25
    Ramnath N,Menezes RJ,Loewen G,Dua P,Eid F,Alkhaddo J,Paganelli G,Natarajan N,Reid ME. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study. Oncology 2007; 73: 305–10.
  • 26
    Chen KY,Hsiao CF,Chang GC,Tsai YH,Su WC,Perng RP,Huang MS,Hsiung CA,Chen CJ,Yang PC. Hormone replacement therapy and lung cancer risk in Chinese. Cancer 2007; 110: 1768–75.
  • 27
    Rodriguez C,Spencer Feigelson H,Deka A,Patel AV,Jacobs EJ,Thun MJ,Calle EE. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2008; 17: 655–60.
  • 28
    Ramanakumar AV,Parent ME,Siemiatycki J. Risk of lung cancer from residential heating and cooking fuels in Montreal, Canada. Am J Epidemiol 2007; 165: 634–42.
  • 29
    IARC. Histological groups for comparative studies. Technical report no. 31. Lyon, France: IARC, 1998.
  • 30
    Langenberg P,Kjerulff KH,Stolley PD. Hormone replacement and menopausal symptoms following hysterectomy. Am J Epidemiol 1997; 146: 870–80.
  • 31
    Leffondre K,Abrahamowicz M,Xiao Y,Siemiatycki J. Modelling smoking history using a comprehensive smoking index: application to lung cancer. Stat Med 2006; 25: 4132–46.
  • 32
    Benedetti A,Parent ME,Siemiatycki J. Consumption of alcoholic beverages and risk of lung cancer: results from two case-control studies in Montreal, Canada. Cancer Causes Control 2006; 17: 469–80.
  • 33
    Leffondre K,Abrahamowicz M,Siemiatycki J,Rachet B. Modeling smoking history: a comparison of different approaches. Am J Epidemiol 2002; 156: 813–23.
  • 34
    Gelfand MM. Role of androgens in surgical menopause. Am J Obstet Gynecol 1999; 180: S325–7.
  • 35
    Hendrix SL. Bilateral oophorectomy and premature menopause. Am J Med 2005; 118 Suppl 12B: 131–5.
  • 36
    Bachmann GA. Vasomotor flushes in menopausal women. Am J Obstet Gynecol 1999; 180: S312–6.
  • 37
    Ettinger B,Friedman GD,Bush T,Quesenberry CP. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996; 87: 6–12.
  • 38
    Purohit A,Reed MJ. Regulation of estrogen synthesis in postmenopausal women. Steroids 2002; 67: 979–83.
  • 39
    Westhoff C,Gentile G,Lee J,Zacur H,Helbig D. Predictors of ovarian steroid secretion in reproductive-age women. Am J Epidemiol 1996; 144: 381–8.
View Full Article (HTML) Get PDF (88K)